Metraipolis › archive › dc_7be2a44df00e

TRMT1-mediated tRNA m22G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma — Europe PMC PMID:42373595

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42373595
DOI: 10.1038/s41419-[numero omesso]-8
License (as archived): solo-consultazione
Archived: 2026-10-31T07:32:23.804Z
SHA-256 of the archived text: aa0418cfd16f1d38c713d2fc1f555028369bfa6c9f32ad195e45977501fce2a0
Stable URL of this page: https://metraipolis.com/documento/dc_7be2a44df00e

How to cite

TRMT1-mediated tRNA m22G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma — Europe PMC PMID:42373595 — Europe PMC (en), https://europepmc.org/article/MED/42373595 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7be2a44df00e (Metraipolis archive dc_7be2a44df00e, sha256 aa0418cfd16f1d38c713d2fc1f555028369bfa6c9f32ad195e45977501fce2a0)

BibTeX

@misc{dc7be2a44df00e,
  title = {TRMT1-mediated tRNA m22G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma — Europe PMC PMID:42373595},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42373595},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7be2a44df00e; sha256 aa0418cfd16f1d38c713d2fc1f555028369bfa6c9f32ad195e45977501fce2a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42373595. Agents can read the archived copy with the MCP tool read_document.